Improved insulin secretion following Intrapancreatic UCB transplantation in patients with T2DM

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 9, 2013, Pages

  Tong, Qiang ^a   Duan, Lian ^a   Xu, Zihui ^a   Wang, Hui ^a   Wang, Xiaocui ^a   Li, Zhongjun ^a   Zhang, Weizhen ^b   Zheng, Hongting ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; C PEPTIDE; GLIMEPIRIDE; GLIPIZIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN;

ADULT; ARTERY; ARTICLE; BLOOD GLUCOSE MONITORING; CASE REPORT; CELL TRANSPLANTATION; CLINICAL TRIAL; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RELEASE; MALE; MICROCATHETER; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS; PANCREAS ARTERY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STEM CELL; TREATMENT RESPONSE; UMBILICAL CORD BLOOD;

ADULT; BLOOD GLUCOSE; C-PEPTIDE; CORD BLOOD STEM CELL TRANSPLANTATION; DIABETES MELLITUS, TYPE 2; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; MALE; PANCREAS; TREATMENT OUTCOME;

EID: 84883658564     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-1451     Document Type: Article

References (18)

1. Fiorina P, Jurewicz M, Augello A, et al. Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes. J Immunol. 2009;183:993-1004.
2. Hess D, Li L, Martin M, et al. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol. 2003;21:763-770.
3. Moriscot C, de Fraipont F, Richard MJ, et al. Human bone marrow mesenchymal stem cells can express insulin and key transcription factors of the endocrine pancreas developmental pathway upon genetic and/or microenvironmental manipulation in vitro. Stem Cells. 2005;23:594-603.
4. Osiris Therapeutics provides update on groundbreaking stem cell trial for type 1 diabetes. Osiris Therapeutics, Inc. web site. http:// investor.osiris.com/releasedetail.cfm?ReleaseID636520.
5. Esmatjes E, Montaña X, Real MI, et al. Regeneration of insulin production by autologous bone marrow blood autotransplantation in patients with type 1 diabetes. Diabetologia. 2010;53:786-789.
6. Peffault de Latour R, Purtill D, Ruggeri A, et al. Influence of nucleated cell dose on overall survival of unrelated cord blood transplantation for patients with severe acquired aplastic anemia: a study by eurocord and the aplastic anemia working party of the European group or blood and marrow transplantation. Biol Blood Marrow Transplant. 2011;17:78-85.
7. Kato K, Yoshimi A, Ito E, et al. Cord blood transplantation from unrelated donors for children with acute lymphoblastic leukemia in Japan: the impact of methotrexate on clinical outcomes. Biol Blood Marrow Transplant 2011;17:1814-1821.
8. Harris DT, Rogers I. Umbilical cord blood: a unique source of pluripotent stem cells for regenerative medicine. Curr Stem Cell Res Ther. 2007;2:301-309.
9. Haller MJ, Wasserfall CH, Hulme MA, et al. Autologous umbilical cord blood transfusion in young children with type 1 diabetes fails to preserve C-peptide. Diabetes Care. 2011;34:2567-2569.
10. Haffner SM, Stern MP, Hazuda HP, Pugh JA, Patterson JK. Hyperinsulinemia in a population at high risk for non-insulin-dependent diabetes mellitus. N Engl J Med. 1986;315:220-224.
11. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2008;31(suppl 1):S55-S60.
12. Harrison LB, Adams-Huet B, Raskin P, Lingvay I. -Cell function preservation after 3.5 years of intensive diabetes therapy. Diabetes Care. 2012;35:1406-1412.
13. Moore KA, Lemischka IR. Stem cells and their niches. Science. 2006; 311:1880-1885.
14. Gao J, Dennis JE, Muzic RF, Lundberg M, Caplan AI. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs. 2001;169:12-20.
15. Bhansali A, Upreti V, Khandelwal N, et al. Efficacy of autologous bone marrow-derived stem cell transplantation in patients with type 2 diabetes mellitus. Stem Cells Dev. 2009;18:1407-1416.
16. Bell GI, Putman DM, Hughes-Large JM, Hess DA. Intrapancreatic delivery of human umbilical cord blood aldehyde dehydrogenaseproducing cells promotes islet regeneration. Diabetologia. 2012;55: 1755-1760.
17. Lin Y, Yang X, Chen Z, et al. Demonstration of the dorsal pancreatic artery by CTA to facilitate superselective arterial infusion of stem cells into the pancreas. Eur J Radiol. 2012;81:461-465.
18. Okahara M, Mori H, Kiyosue H, Yamada Y, Sagara Y, Matsumoto S. Arterial supply to the pancreas; variations and cross-sectional anatomy. Abdom Imaging. 2010;35:134-142.